Prefrontal cortical manipulations alter the effects of intra-ventral striatal dopamine antagonists on fixed-interval performance in the rat

Behavioural Brain Research

Volumn 107, Issue 1-2, 2000, Pages 45-58

  Evans, S B ^b   Cory Slechta, D A ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Agranular insular; Dopamine; Fixed interval; Microinjection; Prefrontal cortex; Prelimbic; Ventrolateral striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; ETICLOPRIDE; LIDOCAINE;

ANIMAL EXPERIMENT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REINFORCEMENT; REVIEW;

EID: 0033991716     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00108-4     Document Type: Article

References (69)

1. Albert D.J., Madryga F.J. An examination of the functionally effective spread of 4 microliters of slowly infused lidocaine. Behav. Neural Biol. 29:1980;378-384.
2. Albert D.J., Wong R.C.K. Hyperreactivity, muricide, and intraspecific aggression in the rat produced by infusion of local anesthetic into the lateral septum or surrounding areas. J. Comp. Physiol. Psychol. 92:1978;1062-1073.
3. Butterworth J., Cole L., Marlow G. Inhibition of brain cell excitability by lidocaine, QX314, and TTX: A mechanism for analgesia from infused local anesthetics? Acta Anaesthesiol. Scand. 37:1993;516-528.
4. Caine S.B., Heinrichs S.C., Coffin V.L., Koob G.F. Effects of the dopamine D-1 antagonist SCH23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692:1995;47-56.
5. Chaillan F.A., Marchetti E., Delfosse F., Roman F.S., Soumireu-Mourat B. Opposite effects depending on learning and memory demands in dorsomedial prefrontal cortex lesioned rats performing an olfactory task. Behav. Brain Res. 82:1997;203-212.
6. Christie M.J., Rowe P.J., Beart P.M. Effect of excitotoxin lesions in the medial prefrontal cortex on cortical and subcortical catecholamine turnover in the rat. J. Neurochem. 47:1986;1593-1597.
7. Cools A.R. Mesolimbic dopamine and its control of locomotor activity in rats: Differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens. Psychopharmacology. 88:1986;451-459.
8. Cory-Slechta D.A. Prolonged lead exposure and fixed ratio performance. Neurobehav. Toxicol. Teratol. 8:1986;237-244.
9. Cory-Slechta D.A., O'Mara D.J., Brockel B.J. Nucleus accumbens dopaminergic mediation of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure. J. Pharmacol. Exp. Ther. 286(3):1998;794-805.
10. Cory-Slechta D.A., Pazmino R., Bare C. The critical role of the nucleus accumbens dopamine systems in the mediation of fixed interval schedule-controlled operant behavior. Brain Res. 764:1997;253-256.
11. Cory-Slechta D.A., Weiss B., Cox C. Performance and exposure indices of rats exposed to low concentrations of lead. Toxicol. Appl. Pharmacol. 78:1985;291-299.
12. Cotman C., Nadler J. Reactive synaptogenesis in the hippocampus. Cotman C. Neuronal Plasticity. 1978;227-271 Raven Press, New York.
13. Dalley J., Thomas K., Howes S., Tsai T., Aparicio-Legarza M., Reynolds G., Everitt B., Robbins T. Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens. Eur. J. Neurosci. 11:1999;1265-1274.
14. Darcheville J.C., Riviere V., Wearden J.H. Fixed-interval performance and self-control in children. J. Exp. Anal. Behav. 57:1992;187-199.
15. Darcheville J.C., Riviere V., Wearden J.H. Fixed-interval performance and self-control in infants. J. Exp. Anal. Behav. 60:1993;239-254.
16. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Uylings H.B.M., Van Eden V.G., De Bruin J.P.C., Corner M.A., Feenstra M.G.P. The Prefrontal Cortex: Its Structure, Function, and Pathology, Progress in Brain Research. 85:1990;367-403 Elsevier, New York.
17. Divac I. Neostriatum and functions of prefrontal cortex. Acta Neurobiol. Exp. 32:1972;461-477.
18. Dunn A.J. Stress-related activation of cerebral dopaminergic systems. Kalivas P.W., Nemeroff C.B. The Mesocorticolimbic Dopamine System. 537:1988;138-147 New York Academy of Sciences, New York.
19. Elliot K., Jasper H. Physiologic salt solutions for brain surgery. J. Neurosurg. 5-6:1948;140-152.
20. Ericson E., Svensson T.H., Ahlenius S. Loss of discriminative avoidance behavior by local application of kynurenic acid into the nucleus accumbens of the rat. Pharmacol. Biochem. Behav. 37:1990;843-845.
21. Evans S.B., Cory-Slechta D.A. The effects of temporary lesions of the insular and medial prefrontal cortex on fixed-interval schedule-controlled behavior in the rat. Soc. Neurosci. Abstr. 22(1):1996;159.
22. Flexner J., Flexner L. Further observations on restoration of memory lost after treatment with puromycin. Yale J. Biol. Med. 42(3):1969;235-240.
23. Flexner J., Flexner L. Puromycin: effect on memory of mice when injected with various cations. Science. 165(898):1969;1143-1144.
24. Flexner J., Flexner L. Restoration of expression of memory lost after treatment with puromycin. Proc. Natl. Acad. Sci. USA. 57:1967;1651-1654.
25. Flexner J., Flexner L., Stellar E. Memory in mice as affected by intracerebral puromycin. Science. 141(57):1963;57-59.
26. Flexner J., Flexner L., Stellar E., De La Haba G., Roberts R. Inhibition of protein synthesis in brain and learning and memory following puromycin. J. Neurochem. 9:1962;595-605.
27. Flexner L., Gambetti P., Flexner J., Roberts R. Studies on memory: distribution of peptidyl-puromycin in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. USA. 68(1):1971;26-28.
28. Fry W., Kelleher R.W., Cook L. A mathematical index of performance on fixed-interval schedules of reinforcement. J. Exp. Anal. Behav. 3:1960;193-199.
29. Gariano R.F., Groves P.M. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res. 462:1988;194-198.
30. Gaykema R.P.A., Van Weeghel R., Hersh L.B., Luiten P. Prefrontal cortical projections to the cholinergic neurons in the basal forebrain. J. Comp. Neurol. 303:1991;563-583.
31. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
32. Groenewegen H.J., Berendse H.W., Wolters J.G., Lohman A.H.M. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization. Uylings H.B.M., Van Eden V.G., De Bruin J.P.C., Corner M.A., Feenstra M.G.P. The Prefrontal Cortex: Its Structure, Function, and Pathology, Progress in Brain Research. 85:1990;95-118 Elsevier, New York.
33. Jaskiw G.E., Hussain G., Meltzer H.Y. Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine. Biol. Psychiatry. 34:1993;188-190.
34. Jaskiw G.E., Karonm F., Freed W.J., Phillips I., Kleinman J.E., Weinberger D.R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res. 534:1990;263-272.
35. Kaddis F.G., Wallace L.J., Uretsky N.J. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists. Pharmacol. Biochem. Behav. 46:1993;703-708.
36. Karreman M., Moghaddam B. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: An effect mediated by ventral tegmental area. J. Neurochem. 66:1996;589-598.
37. Kondziolka D., Bonaroti E., Baser S., Brandt F., Kim Y., Lunsford L. Outcomes after stereotactically guided pallidotomy for advanced Parkinson's disease. J. Neurosurg. 90(2):1999;197-202.
38. Kupsch A., Earl C. Neurosurgical interventions in the treatment of idiopathic parkinson disease: neurostimulation and neural implantation. J. Mol. Med. 77(1):1999;178-184.
39. Leigh K., Elisevich K., Daley S., Rogers K. Effects of injection mechanics, pH of infusate and 6-hydroxydopamine on cerebromicrovascular permeability. Brain Res. 539:1991;271-275.
40. Leonard C.M. The prefrontal cortex of the rat. I. Cortical projection of the mediodorsal nucleus. II. Efferent connections. Brain Res. 12(2):1969;321-343.
41. Manning F.J. Performance under temporal schedules by monkeys with partial ablations of prefrontal cortex. Physiol. Behav. 11:1973;563-569.
42. Martin J.H. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neurosci. Lett. 127:1991;160-164.
43. Martin J.H., Ghez C. Red nucleus and motor cortex: Parallel motor systems for the initiation and control of skilled movement. Behav. Brain Res. 28:1988;217-223.
44. Meyer M.E. Effects of intraaccumbens dopamine agonist SK&F38393 antagonist SCH23390 on locomotor activities in rats. Pharmacol. Biochem. Behav. 45:1993;843-847.
45. Murase S., Grenhoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157:1993;53-56.
46. Nasser J., Confort C., Ferraz A., Bouza A. Preliminary results in surgery of Parkinson's disease. Arq. Neuropsiquiatr. 56(3B):1998;533-539.
47. Neill D.B. Frontal-striatal control of behavioral inhibition in the rat. Brain Res. 105:1976;89-103.
48. Olton D.S. Frontal cortex, timing and memory. Neuropsychologia. 27(1):1989;121-130.
49. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn:1986;Academic Press, San Diego.
50. Pennartz C.M., Groenewegen H.J., Lopes Da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: An integration of behavioral, electrophysiological and anatomical data. Prog. Neurobiol. 42:1994;719-761.
51. Pribram K.H. A further experimental analysis of the behavioral deficit that follows injury to the primate frontal cortex. Exp. Neurol. 3:1961;432-466.
52. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Mol. Pharmacol. 40:1991;756-765.
53. Reibaud M., Blanc G., Studler J., Glowinski J., Tassin J. Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens. Brain Res. 305:1984;43-50.
54. Rice D.C. Lead exposure during different developmental periods produces different effects on FI performance in monkeys tested as juveniles and adults. Neurotoxicology. 13:1992;757-770.
55. Robbins T.W., Roberts D.C.S., Koob G.F. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. J. Pharmacol. Exp. Ther. 224:1983;662-673.
56. Robinson N. Histochemical changes in neocortex and corpus callosum after intracranial injection. J. Neurol. Neurosurg. Psychiatry. 32:1969;317-332.
57. Rosvold H.E. The frontal lobe system: Cortical-subcortical interrelationships. Acta Neurobiol. Exp. 32:1972;439-460.
58. Sabel B., Labbe R., Stein D. The saline effect: minimizing the severity of brain damage by reduction of secondary degeneration. Exp. Neurol. 88:1985;95-107.
59. Sabel B., Stein D. Intracerebral injections of isotonic saline prevent behavioral deficits from brain damage. Physiol. Behav. 28:1982;1017-1023.
60. Seamans J.K., Floresco S.B., Phillips A.G. Functional differences between the prelimbic and anterior cingulate regions of the rat prefrontal cortex. Behav. Neurosci. 109:1995;1063-1073.
61. Snapper A.G., Kadden R.M., Inglis G.B. State notation of behavioral procedures. Behav. Res. Methods Instrum. 14:1982;329-342.
62. Svensson L., Ahlenius S. Suppression of exploratory locomotor activity in the rat by local application of 3-PPP enantiomers into the nucleus accumbens. Eur. J. Pharmacol. 88:1983;393-397.
63. Svensson T.H., Tung C.S. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 136:1989;135-136.
64. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: Modulation by metabotropic glutamate receptors. J. Neurosci. 15(5):1995;3896-3904.
65. Tehovnik E., Sommer M. Effective spread and timecourse of neural inactivation caused by lidocaine injection in monkey cerebral cortex. J. Neurosci. Methods. 74:1997;17-26.
66. Will B., Toniolo G., Brailowsky S. Unilateral infusion of GABA and saline into the nucleus basalis of rats: 1. Effects on motor function and brain morphology. Behav. Brain Res. 27(2):1988;123-129.
67. Wolfarth S., Boissier J. On the choice of so-called placebo solution for the intranigral microinjection in the rat. Pol. J. Pharmacol. Pharm. 28(1):1976;27-36.
68. You Z., Tzschentke T.M., Brodin E., Wise R.A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: An In Vivo microdialysis study in freely moving rats. J. Neurosci. 18(16):1998;6492-6500.
69. Zilles K., Zilles B., Schleicher A. A quantitative approach to cytoarchitectonics. Anat. Embryol. 159:1980;335-360.